Cochlear Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
|Primary activities||Manufacture and sale of Cochlear implant systems.|
|Industry / Sector||Medical Devices / Healthcare|
|Full time employees||4000|
|Mailing address||1 University Avenue Macquarie University Sydney NSW 2109 Australia|
|Phone / Fax||61 2 9428 6555 / 61 2 9428 6353|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
|20 Aug 2020||Corrections to 2020 Annual Report|
|17 Aug 2020||2020 Annual Report|
Cochlear paid $1.15 dividend and the ex-dividend date was 25 Mar 2021.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.COH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
COH's forward dividend amount is $1.15 and the forward dividend yield is 0.53%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of May 2021, following are the company executives and directors listed on Cochlear.
|Mr. Diggory William Howitt BE (Hons), MBA||CEO, MD, Pres & Exec. Director||53||2.08M|
|Mr. Jan Janssen||Chief Technology Officer||971.19k|
|Mr. Richard Brook||Pres of EMEA & Latin American Region||1.26M|
|Mr. Anthony Manna||Pres of Americas Region||1.03M|
|Mr. Anthony Bishop||Pres of Asia Pacific Region||638.04k|
|Mr. Stuart Sayers||CFO & Pres of Services|
|Mr. David Hackshall||Chief Information Officer|
|Ms. Kristina Devon||VP of Investor Relations|
|Ms. Jennifer Stevenson||VP of Corp. Communications|
|Mr. Dean Phizacklea||Sr. VP of Global Marketing|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cochlear is 14.36B and its enterprise value is 14.05B. The enterprise value to revenue ratio of COH is 10.74.
The COH's stocks Beta value is 0.37 making it 63% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Cochlear (COH)
- Ansell (ANN)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Cochlear (ASX:COH) Frequently Asked Questions
1. What is Cochlear's Stock Symbol?
Cochlear trades on ASX under the ticker symbol "COH".
2. What is Cochlear's stock price today?
One share of COH stock can currently be purchased for approximately $218.46.
3. How can I contact Cochlear?
Cochlear's mailing address is 1 University Avenue Macquarie University Sydney NSW 2109 Australia. The company can be reached via phone at 61 2 9428 6555.
4. What is Cochlear's official website?
The official website of Cochlear is http://www.cochlear.com.
5. Which share registry manages Cochlear's stock?
Cochlear's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.